News | February 01, 2024
Zydus Lifesciences launches Rexigo
This is the first and only oral once-a-day therapy for testosterone suppression in patients with advanced prostate cancer in India
This is the first and only oral once-a-day therapy for testosterone suppression in patients with advanced prostate cancer in India
The company will be preferred business partner for VPPL in terms of sourcing and supplying key raw materials
Astec LifeSciences has reported total income of Rs. 51.70 crores during the period ended December 31, 2023
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
This PAI-cum-GMP USFDA inspection was conducted from December 14 to December 22, 2023
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Eris Lifesciences enters into term loan agreement with Citi Bank
The company has reported total income of Rs. 75.26 crores during the period ended June 30, 2023
Astec LifeSciences has reported total income of Rs. 144.55 crores during the period ended June 30, 2023
Eris Lifesciences has reported total income of Rs. 403.80 crores during the period ended March 31, 2023
Subscribe To Our Newsletter & Stay Updated
